PY
PYC Therapeutics Limited
PYC.AX · ASX
$2.51 +0.00% (+$0.00)
1M +20.10%
Market Cap $1.46B
P/E Ratio -
Div. Yield -
ROE 16.27%
Bulios Fair Price
$1.96
21.9% downside
Trenutna cena
$2.51
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PYC.AX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
85 /100
Cheap P/B 2.11x
EV/FFO N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 192.34%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 16.27%
ROA 6.12%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 33.48x
Int. coverage -2,043.25x
Debt/Equity 0.00x
Stability
20 /100
Unstable Rev. volatility 72.93%
EPS volatility 546.12%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PYC.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Rohan Hockings
Employees
37
Headquarters
Nedlands
Prihajajoči dogodki
01 MAR.
Earnings
Upcoming earnings report